Login / Signup

Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies.

Hiroshi NagaseNaoshi YamamotoMasahiro YataSayaka OhruiTakahiro OkadaTsuyoshi SaitohNoriki KutsumuraYasuyuki NagumoYoko Irukayama-TomobeYukiko IshikawaYasuhiro OgawaShigeto HirayamaDaisuke KurodaYurie WatanabeHiroaki GoudaMasashi Yanagisawa
Published in: Journal of medicinal chemistry (2017)
Nalfurafine, a κ-selective opioid receptor agonist, unexpectedly showed a selective antagonist activity toward the orexin 1 receptor (OX1R) (Ki = 250 nM). Modification of the 17-amino side chain of the opioid ligand to an arylsulfonyl group and the 6-furan acrylamide chain to 2-pyridyl acrylamide led to compound 71 with improvement of the antagonist activity (OX1R, Ki = 1.36 nM; OX2R, not active) without any detectable affinity for the opioid receptor. The dihydrosulfate salt of 71, freely soluble in water, attenuated the physical dependence of morphine. Furthermore, all of the active nalfurafine derivatives in this study had almost no activity for OX2R, which led to high OX1R selectivity. These results suggest that nalfurafine derivatives could be a useful series of lead compounds to develop highly selective OX1R antagonists.
Keyphrases
  • chronic pain
  • pain management
  • low density lipoprotein
  • photodynamic therapy
  • physical activity
  • mental health
  • neoadjuvant chemotherapy
  • radiation therapy
  • lymph node
  • anti inflammatory